Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$57.56 - $82.54 $163,470 - $234,413
-2,840 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$72.5 - $100.68 $143,695 - $199,547
-1,982 Reduced 41.1%
2,840 $221,000
Q2 2021

Jul 12, 2021

SELL
$93.66 - $139.27 $23,508 - $34,956
-251 Reduced 4.95%
4,822 $599,000
Q1 2021

Apr 22, 2021

SELL
$116.57 - $155.01 $51,057 - $67,894
-438 Reduced 7.95%
5,073 $669,000
Q4 2020

Jan 25, 2021

BUY
$99.61 - $142.12 $67,734 - $96,641
680 Added 14.08%
5,511 $730,000
Q3 2020

Oct 16, 2020

BUY
$72.92 - $102.01 $98,952 - $138,427
1,357 Added 39.06%
4,831 $493,000
Q2 2020

Jul 08, 2020

BUY
$55.75 - $92.75 $193,675 - $322,213
3,474 New
3,474 $302,000
Q3 2019

Nov 06, 2019

SELL
$90.37 - $122.49 $179,294 - $243,020
-1,984 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $177,587 - $234,191
1,984 New
1,984 $234,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.